FOURTH AMENDMENT TO SUBLEASESublease • March 5th, 2013 • Infinity Pharmaceuticals, Inc. • Pharmaceutical preparations
THIS FOURTH AMENDMENT TO SUBLEASE (“Amendment”) is made as of the 19th day of December, 2012 (the “Effective Date”), by and between INFINITY DISCOVERY, INC., a Delaware corporation (“Sublandlord”), and HYDRA BIOSCIENCES, INC., a Delaware corporation (“Subtenant”).
December 24, 2012 AMENDED AND RESTATED DEVELOPMENT AND LICENSE AGREEMENT Between INTELLIKINE LLC and INFINITY PHARMACEUTICALS, INC.Development and License Agreement • March 5th, 2013 • Infinity Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
This Amended and Restated Development and License Agreement (“Agreement”) is made as of this 24th day of December, 2012 (the “Effective Date”) by and between Intellikine LLC, a limited liability company organized and existing under the laws of the State of Delaware and successor to Intellikine, Inc. (“Intellikine”), and Infinity Pharmaceuticals, Inc., a company organized and existing under the laws of the State of Delaware (“Infinity”). Intellikine and Infinity are each referred to individually as a “Party” and together as the “Parties”.
